Status:
COMPLETED
Screening for Bleeding Disorders in Children
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Bleeding Disorder
Eligibility:
All Genders
Up to 18 years
Brief Summary
The investigators try to improve the screening of bleeding disorders in children by identifying symptoms, laboratory abnormalities and clinical scores discriminating patients congenital bleeding disor...
Detailed Description
Objective : To determine simple clinical and biological factors that can improve the screening of hemostatic diseases at risk of hemorrhage in children. Method: * Retrospective inclusion of all pati...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- referred by their general practitioner or another caring physician for evaluation of bleeding symptoms
- abnormal laboratory test results or family study
- the patient being the first-degree relative of a patient with a known bleeding disorder.
- Exclusion criteria:
- \- older than 18 years old.
Exclusion
Key Trial Info
Start Date :
December 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 20 2021
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT05214300
Start Date
December 1 2019
End Date
December 20 2021
Last Update
January 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295